Speculation on the pathophysiology of musculoskeletal injury with COVID-19 infection.

ACE2 COVID-19 bone inflammation joint muscle

Journal

Frontiers in medicine
ISSN: 2296-858X
Titre abrégé: Front Med (Lausanne)
Pays: Switzerland
ID NLM: 101648047

Informations de publication

Date de publication:
2022
Historique:
received: 28 04 2022
accepted: 28 06 2022
entrez: 1 8 2022
pubmed: 2 8 2022
medline: 2 8 2022
Statut: epublish

Résumé

Coronavirus disease 2019 (COVID-19) primarily affects the respiratory tract, but also many other organs and tissues, leading to different pathological pictures, such as those of the musculoskeletal tissues. The present study should be considered as a speculation on the relationship between COVID-19 infection and some frequent musculoskeletal pathologies, in particular sarcopenia, bone loss/osteoporosis (OP) and fracture risk and osteoarthritis (OA), to hypothesize how the virus acts on these pathologies and consequently on the tissue regeneration/healing potential. The study focuses in particular on the modalities of interaction of COVID-19 with Angiotensin-Converting Enzyme 2 (ACE2) and on the "cytokine storm." Knowing the effects of COVID-19 on musculoskeletal tissues could be important also to understand if tissue regenerative/reparative capacity is compromised, especially in elderly and frail patients. We speculate that ACE2 and serine proteases together with an intense inflammation, immobilization and malnutrition could be the responsible for muscle weakness, altered bone remodeling, increase in bone fracture risk and inflammatory joint pathologies. Future preclinical and clinical studies may focus on the regenerative/reparative properties of the musculoskeletal tissues after COVID-19 infection, toward a personalized treatment usually based on scaffolds, cells, and growth factors.

Identifiants

pubmed: 35911401
doi: 10.3389/fmed.2022.930789
pmc: PMC9329661
doi:

Types de publication

Journal Article

Langues

eng

Pagination

930789

Informations de copyright

Copyright © 2022 Veronesi, Contartese, Martini, Visani and Fini.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Arthritis Rheumatol. 2017 Aug;69(8):1601-1611
pubmed: 28464560
Bone. 2019 Nov;128:115041
pubmed: 31442676
Biochem Biophys Res Commun. 2004 Feb 6;314(2):654-8
pubmed: 14733957
Cancer Lett. 2018 Dec 1;438:32-43
pubmed: 30201302
Neurol Sci. 2021 Jun;42(6):2173-2178
pubmed: 33755815
Infection. 2022 Jun 2;:
pubmed: 35655110
Cell. 2020 Apr 16;181(2):271-280.e8
pubmed: 32142651
Bone Joint J. 2020 Sep;102-B(9):1136-1145
pubmed: 32634023
Circ Res. 2020 May 8;126(10):1456-1474
pubmed: 32264791
Am J Trop Med Hyg. 2020 Aug;103(2):847-850
pubmed: 32563271
Microb Pathog. 2021 Jan;150:104673
pubmed: 33278517
JBJS Rev. 2022 Jun 3;10(6):
pubmed: 35658089
N Engl J Med. 2014 Apr 24;370(17):1626-35
pubmed: 24758618
J Bone Joint Surg Am. 2020 Jul 1;102(13):e69
pubmed: 32618917
Curr Drug Targets Inflamm Allergy. 2005 Jun;4(3):325-8
pubmed: 16101541
Clin Rheumatol. 2020 Jul;39(7):2103-2104
pubmed: 32458242
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
J Appl Physiol (1985). 2020 Oct 1;129(4):864-867
pubmed: 32673162
Acta Biomed. 2020 May 11;91(2):89-96
pubmed: 32420932
J Am Med Dir Assoc. 2014 Feb;15(2):95-101
pubmed: 24461239
Int J Biol Sci. 2021 Mar 25;17(5):1277-1288
pubmed: 33867845
Orthop Res Rev. 2021 Sep 21;13:141-150
pubmed: 34584465
Comput Struct Biotechnol J. 2020;18:2438-2444
pubmed: 32905022
Arthritis Rheum. 2010 Jul;62(7):1955-66
pubmed: 20506309
J Patient Exp. 2022 May 23;9:23743735221102678
pubmed: 35647269
Front Endocrinol (Lausanne). 2020 Apr 09;11:165
pubmed: 32328030
Bone Jt Open. 2021 May;2(5):314-322
pubmed: 34003031
Int J Mol Sci. 2022 May 17;23(10):
pubmed: 35628399
Cell Death Differ. 2017 Apr;24(4):672-682
pubmed: 28106886
Muscle Nerve. 2020 Sep;62(3):E57-E60
pubmed: 32535934
J Orthop Trauma. 2020 Aug;34(8):395-402
pubmed: 32482976
J Bone Joint Surg Am. 2020 Jul 15;102(14):1197-1204
pubmed: 32675661
Front Immunol. 2016 Sep 22;7:378
pubmed: 27713747
Calcif Tissue Int. 2021 Oct;109(4):351-362
pubmed: 34003337
Arch Virol. 2009;154(9):1457-64
pubmed: 19685004
Recent Adv Inflamm Allergy Drug Discov. 2022 Mar 18;:
pubmed: 35307003
Bone Joint J. 2020 Oct;102-B(10):1279-1280
pubmed: 32993335
Braz J Med Biol Res. 2010 Sep;43(9):837-42
pubmed: 20802975
J Infect. 2020 Jun;80(6):607-613
pubmed: 32283152
Am J Trop Med Hyg. 2020 Sep;103(3):1158-1161
pubmed: 32729460
Eur J Orthop Surg Traumatol. 2021 Feb;31(2):341-347
pubmed: 32886249
J Affect Disord. 2022 Jan 15;297:233-245
pubmed: 34699853
Front Endocrinol (Lausanne). 2013 Aug 26;4:106
pubmed: 23986744
Front Med (Lausanne). 2020 Dec 03;7:594495
pubmed: 33344479
Emerg Infect Dis. 2020 Jul;26(7):1618-1620
pubmed: 32197060
Cureus. 2020 Mar 26;12(3):e7423
pubmed: 32337143
Clin Gastroenterol Hepatol. 2020 Nov;18(12):2847-2848
pubmed: 32407784
J Pathol. 2020 Jul;251(3):228-248
pubmed: 32418199
Front Immunol. 2021 Apr 13;12:666693
pubmed: 33927728
J Orthop Traumatol. 2021 Apr 5;22(1):15
pubmed: 33818650
PLoS One. 2014 Apr 02;9(4):e93449
pubmed: 24695436

Auteurs

Francesca Veronesi (F)

Complex Structure of Surgical Sciences and Technologies, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy.

Deyanira Contartese (D)

Complex Structure of Surgical Sciences and Technologies, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy.

Lucia Martini (L)

Complex Structure of Surgical Sciences and Technologies, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy.

Andrea Visani (A)

Complex Structure of Surgical Sciences and Technologies, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy.

Milena Fini (M)

Complex Structure of Surgical Sciences and Technologies, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy.

Classifications MeSH